Charles B. Kemmler

Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins

Aurelia A. Haller, Georg M. Lauer, Thomas H. King et al. · Vaccine · 2006 · 105 citations

Adaptive Immune System, T-regulatory Cell, Immunology +9

A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance

Thomas H. King, Charles B. Kemmler, Zhimin Guo et al. · PLoS ONE · 2014 · 69 citations · Full text

Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens

Kimberly R. Jordan, Rachel H. McMahan, Charles B. Kemmler et al. · Proceedings of the National Academy of Sciences · 2010 · 68 citations · Full text

T-regulatory Cell, Immunology, Immunoediting +18

Age-dependent tolerance to an endogenous tumor-associated antigen

Jennifer McWilliams, Richard Sullivan, Kimberly R. Jordan et al. · Vaccine · 2008 · 37 citations · Full text

Cancer Immunosurveillance, Age-dependent Tolerance, Immunology +7

Augmenting Antitumor T-Cell Responses to Mimotope Vaccination by Boosting with Native Tumor Antigens

Jonathan D. Buhrman, Kimberly R. Jordan, Lance U’Ren et al. · Cancer Research · 2012 · 17 citations · Full text